Top Markets
Coin of the day
Sandoz Group AG Sandoz Group AG

Sandoz Group AG

SDZ
Rangering i aksjer #622
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Aksjekurs
$95.44
Sist synkronisert: 2026-08-24
Markedsverdi
$41.29B
Endring (1 dag)
-0.62%
Endring (1 år)
52.20%
Land
CH
Handel Sandoz Group AG (SDZ)

Kategori

P/B-forhold for Sandoz Group AG (SDZ)
P/B-forhold per 2026 TTM: 0
Ifølge Sandoz Group AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Sandoz Group AG fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter